scholarly article | Q13442814 |
P2093 | author name string | R Schlegel | |
J Anders | |||
M Mense | |||
J Sparkowski | |||
P2860 | cites work | Vacuolar H(+)-ATPase mutants transform cells and define a binding site for the papillomavirus E5 oncoprotein | Q28115609 |
E5 open reading frame of bovine papillomavirus type 1 encodes a transforming gene | Q28286988 | ||
Animal papillomaviruses. | Q33626481 | ||
The E5 oncoprotein of bovine papillomavirus binds to a 16 kd cellular protein | Q33916978 | ||
Translation of open reading frame E5 of bovine papillomavirus is required for its transforming activity | Q35595257 | ||
Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous beta receptor for platelet-derived growth factor in mouse C127 cells. | Q35846414 | ||
Mutational analysis of the beta-type platelet-derived growth factor receptor defines the site of interaction with the bovine papillomavirus type 1 E5 transforming protein. | Q35849030 | ||
Membrane-anchored form of v-sis/PDGF-B induces mitogenesis without detectable PDGF receptor autophosphorylation | Q36529579 | ||
Ligand-independent activation of the platelet-derived growth factor beta receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling | Q36550896 | ||
The bovine papillomavirus type 1 E5 transforming protein specifically binds and activates the beta-type receptor for the platelet-derived growth factor but not other related tyrosine kinase-containing receptors to induce cellular transformation | Q36622401 | ||
Specific interaction between the bovine papillomavirus E5 transforming protein and the beta receptor for platelet-derived growth factor in stably transformed and acutely transfected cells | Q36634049 | ||
Mutation of the bovine papillomavirus E5 oncoprotein at amino acid 17 generates both high- and low-transforming variants | Q36635620 | ||
Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain | Q36651868 | ||
A glutamine residue in the membrane-associating domain of the bovine papillomavirus type 1 E5 oncoprotein mediates its binding to a transmembrane component of the vacuolar H(+)-ATPase | Q36656196 | ||
Platelet-derived growth factor receptor can mediate tumorigenic transformation by the bovine papillomavirus E5 protein | Q36690316 | ||
The conserved C-terminal domain of the bovine papillomavirus E5 oncoprotein can associate with an alpha-adaptin-like molecule: a possible link between growth factor receptors and viral transformation | Q36824208 | ||
44-amino-acid E5 transforming protein of bovine papillomavirus requires a hydrophobic core and specific carboxyl-terminal amino acids | Q36846314 | ||
Evidence that the deep keratin filament systems of the Xenopus embryo act to ensure normal gastrulation. | Q37208255 | ||
Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines | Q37611813 | ||
E5 oncoprotein retained in the endoplasmic reticulum/cis Golgi still induces PDGF receptor autophosphorylation but does not transform cells | Q37619573 | ||
Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements | Q37669730 | ||
In vitro induction of continuous acute promyelocytic leukemia cell lines by Friend or Abelson murine leukemia virus | Q40222820 | ||
Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein | Q41080345 | ||
An intact PDGF signaling pathway is required for efficient growth transformation of mouse C127 cells by the bovine papillomavirus E5 protein. | Q41351225 | ||
erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells | Q42807469 | ||
The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors | Q42835148 | ||
Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization | Q45383630 | ||
A quantitative in vitro focus assay for bovine papilloma virus | Q45803536 | ||
Characterization of bovine papillomavirus type 1-transformed clones which show distinct transformed phenotypes. | Q53515084 | ||
The E5 transforming gene of bovine papillomavirus encodes a small, hydrophobic polypeptide. | Q54144933 | ||
Genetic analysis of the 3' early region transformation and replication functions of bovine papillomavirus type 1. | Q64956444 | ||
Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells | Q68090789 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | phosphorylation | Q242736 |
transmembrane protein | Q424204 | ||
P304 | page(s) | 2420-2430 | |
P577 | publication date | 1996-04-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation | |
P478 | volume | 70 |
Q81298973 | Are transforming properties of the bovine papillomavirus E5 protein shared by E5 from high-risk human papillomavirus type 16? |
Q33482628 | Artificial transmembrane oncoproteins smaller than the bovine papillomavirus E5 protein redefine sequence requirements for activation of the platelet-derived growth factor beta receptor |
Q33575831 | Bovine papillomavirus E5 protein induces oligomerization and trans-phosphorylation of the platelet-derived growth factor beta receptor |
Q28594481 | Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding |
Q43581315 | Bovine papillomavirus oncoprotein E5 affects the arachidonic acid metabolism in cells. |
Q33835105 | Cooperative transformation and coexpression of bovine papillomavirus type 1 E5 and E7 proteins |
Q38311773 | ErbB4 (JM-b/CYT-1)-induced expression and phosphorylation of c-Jun is abrogated by human papillomavirus type 16 E5 protein |
Q41820272 | Golgi alkalinization by the papillomavirus E5 oncoprotein |
Q35895171 | Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein |
Q40794484 | Identification of the transmembrane dimer interface of the bovine papillomavirus E5 protein |
Q22010594 | Mechanism of action and in vivo role of platelet-derived growth factor |
Q33183198 | Mechanisms of cell transformation by papillomavirus E5 proteins |
Q41361382 | Multiplicity of uses of monoclonal antibodies that define papillomavirus linear immunodominant epitopes |
Q40638007 | Oligomerization of the E5 protein of human papillomavirus type 16 occurs through multiple hydrophobic regions. |
Q35057000 | Organelle acidification and disease |
Q40471258 | Productive interaction between transmembrane mutants of the bovine papillomavirus E5 protein and the platelet-derived growth factor beta receptor. |
Q39582036 | Role of glutamine 17 of the bovine papillomavirus E5 protein in platelet-derived growth factor beta receptor activation and cell transformation. |
Q40245388 | Suprabasal overexpression of beta-1 integrin is induced by bovine papillomavirus type 1. |
Q34754347 | The E5 proteins |
Q33644980 | The bovine papillomavirus E5 protein requires a juxtamembrane negative charge for activation of the platelet-derived growth factor beta receptor and transformation of C127 cells |
Q33180948 | The platelet-derived growth factor beta receptor as a target of the bovine papillomavirus E5 protein |
Q24530182 | The vacuolar H+-ATPase: a universal proton pump of eukaryotes |
Q41374895 | Virocrine transformation |
Q42518739 | c-Src activation by the E5 oncoprotein enables transformation independently of PDGF receptor activation |
Search more.